Baxter International quarterly profit that tops estimates

Deerfield-based Baxter International Inc., the maker of hemophilia treatments that's splitting into two companies, reported first-quarter profit that topped analysts' estimates.

Profit excluding some items was $1 a share, Baxter said in a statement. Analysts had estimated 88 cents on average, according to data compiled by Bloomberg.

The company forecast second-quarter profit from continuing operations that trailed estimates.

Profit excluding certain items will be 92 cent to 96 cents a share. Analysts had forecast $1.02 on average.